LING-YING WEISANG-HENG KOKLee, Yen-ChingYen-ChingLeeWEI-YIH CHIUWang, Jai-JenJai-JenWangSHIH-JUNG CHENGHAO-HUENG CHANGJANG-JAER LEE2022-06-272022-06-272022-011354-523Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/613354The aim of this study was to find out the prognosis of medication-related osteonecrosis of the jaws (MRONJ) in prostate cancer patients who received two different types of antiresorptive agents for bone metastasis.enC-terminal telopeptide of collagen I (CTX); denosumab; medication-related osteonecrosis of the jaws (MRONJ); prognosis; prostate cancer; zoledronic acid[SDGs]SDG3journal article10.1111/odi.13737332542782-s2.0-85106813086WOS:000598397500001https://scholars.lib.ntu.edu.tw/handle/123456789/571202